enVVeno Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February. At this time, EnVVeno Medical's Cash And Short Term Investments are very stable compared to the past year. As of the 18th of January 2025, Common Stock Shares Outstanding is likely to grow to about 14.9 M, while Property Plant And Equipment Net is likely to drop about 1.1 M. Key indicators impacting EnVVeno Medical's financial strength include:
The essential information of the day-to-day investment outlook for EnVVeno Medical includes many different criteria found on its balance sheet. An individual investor should monitor EnVVeno Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in EnVVeno Medical.
EnVVeno Medical competes with Ainos, SurModics, LENSAR, IRIDEX, and Rxsight. enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Envveno Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Comparative valuation techniques use various fundamental indicators to help in determining EnVVeno Medical's current stock value. Our valuation model uses many indicators to compare EnVVeno Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EnVVeno Medical competition to find correlations between indicators driving EnVVeno Medical's intrinsic value. More Info.
enVVeno Medical Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, EnVVeno Medical's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EnVVeno Medical's earnings, one of the primary drivers of an investment's value.
enVVeno Medical Corp Systematic Risk
EnVVeno Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EnVVeno Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on enVVeno Medical Corp correlated with the market. If Beta is less than 0 EnVVeno Medical generally moves in the opposite direction as compared to the market. If EnVVeno Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one enVVeno Medical Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EnVVeno Medical is generally in the same direction as the market. If Beta > 1 EnVVeno Medical moves generally in the same direction as, but more than the movement of the benchmark.
EnVVeno Medical Thematic Clasifications
enVVeno Medical Corp is part of Medical Equipment investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in EnVVeno Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EnVVeno Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of EnVVeno Medical growth as a starting point in their analysis.
EnVVeno Medical January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EnVVeno Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of enVVeno Medical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of enVVeno Medical Corp based on widely used predictive technical indicators. In general, we focus on analyzing EnVVeno Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EnVVeno Medical's daily price indicators and compare them against related drivers.
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.37)
Return On Equity
(0.59)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.